Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429001 | PMC |
| http://dx.doi.org/10.3389/fphar.2019.00218 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Neuropharmacological Advances: Harnessing 5-HT2A Receptor Modulators and Psychoplastogens.
ACS Med Chem Lett
February 2024
Usona Institute, Fitchburg, Wisconsin 53711-5300, United States.
This Patent Highlight explores the emerging role of 5-HT2A receptor modulators and psychoplastogens in neuropsychiatric treatment. It delves into these novel compounds' molecular mechanisms, therapeutic potential, and challenges, highlighting their therapeutic potential in mental health care.
View Article and Find Full Text PDFEditorial: Neuropharmacological and neurotoxicological advances using non-mammalian model organisms.
Front Neurosci
September 2023
Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong, China.
Safety pharmacology 2023 and implementation of the ICH E14/S7B Q&A guidance document.
J Pharmacol Toxicol Methods
November 2023
Cardiovascular Division, King's College London, Rayne Institute, St Thomas' Hospital, London SE17EH, UK.
This editorial prefaces the annual themed issue on safety pharmacology (SP) methods published since 2004 in the Journal of Pharmacological and Toxicological Methods (JPTM). We highlight here the content derived from the recent 2022 Safety Pharmacology Society (SPS) and Canadian Society of Pharmacology and Therapeutics (CSPT) joint meeting held in Montreal, Quebec, Canada. The meeting also generated 179 abstracts (reproduced in the current volume of JPTM).
View Article and Find Full Text PDFEditorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, Volume II.
Front Pharmacol
March 2023
Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), Instituto Universitario de Investigación Neuroquímica (IUIN-UCM), Madrid, Spain.
Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, volume I.
Front Pharmacol
September 2022
Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), Instituto Universitario de Investigación en Neuroquímica (IUIN-UCM), Madrid, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!